Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126425901 | 12642590 | 1 | I | 201512 | 20160704 | 20160810 | 20160810 | EXP | FR-AMGEN-FRANI2016090508 | AMGEN | 60.00 | YR | A | F | Y | 53.00000 | KG | 20160810 | MD | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126425901 | 12642590 | 1 | PS | etanercept | ETANERCEPT | 1 | Subcutaneous | 50 MG, ONCE EVERY 2 WEEKS | U | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126425901 | 12642590 | 1 | Psoriasis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126425901 | 12642590 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126425901 | 12642590 | Condition aggravated | |
126425901 | 12642590 | Drug ineffective | |
126425901 | 12642590 | Psoriasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126425901 | 12642590 | 1 | 20140709 | 0 |